N Friedmann Selected Research

Simufilam

1/2020

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Friedmann Research Topics

Disease

1	Neuroinflammatory Diseases 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Dementia (Dementias) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2013

Drug/Important Bio-Agent (IBA)

1	SimufilamIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	EnzymesIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	InterleukinsIBA 01/2020
1	CytokinesIBA 01/2020
1	NeurograninIBA 01/2020
1	FilaminsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Melanins (Melanin)IBA 01/2013

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2020
1	Therapeutics 01/2013